The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Anxiety and Related Sleep Disorders market in United Arab Emirates is experiencing significant growth due to increasing customer preferences for alternative therapies and the rising prevalence of mental health disorders. Customer preferences in the Anxiety and Related Sleep Disorders market in United Arab Emirates are shifting towards alternative therapies and natural remedies. Customers are increasingly seeking non-pharmacological treatments such as cognitive-behavioral therapy, relaxation techniques, and herbal supplements to manage their anxiety and sleep disorders. This preference is driven by a growing awareness of the potential side effects of traditional medications and a desire for more holistic approaches to healthcare. The market is also being driven by the rising prevalence of mental health disorders in United Arab Emirates. Anxiety disorders and sleep disorders are becoming more common in the population, with factors such as work-related stress, lifestyle changes, and social pressures contributing to the increase in these conditions. As a result, there is a growing demand for treatments and therapies that can effectively address these issues and improve overall mental well-being. In addition to customer preferences and the prevalence of mental health disorders, there are several trends in the Anxiety and Related Sleep Disorders market in United Arab Emirates. One trend is the increasing availability and accessibility of mental health services. Healthcare providers are recognizing the importance of mental health and are expanding their services to include specialized clinics and programs for anxiety and sleep disorders. This trend is making it easier for individuals to seek help and receive appropriate treatment for their conditions. Another trend is the integration of technology in the management of anxiety and sleep disorders. Mobile applications and wearable devices are being developed to help individuals track and manage their symptoms, monitor their sleep patterns, and access resources and support. These technological advancements are empowering individuals to take a proactive approach to their mental health and are providing them with tools to better understand and manage their conditions. Local special circumstances in United Arab Emirates, such as cultural factors and government initiatives, also play a role in the development of the Anxiety and Related Sleep Disorders market. The stigma surrounding mental health is gradually decreasing, leading to increased awareness and acceptance of these conditions. The government has also taken steps to improve mental health services and support, including the establishment of mental health centers and the integration of mental health into primary healthcare services. These efforts are contributing to a more favorable environment for the growth of the Anxiety and Related Sleep Disorders market. Underlying macroeconomic factors, such as the overall economic growth and increasing healthcare expenditure in United Arab Emirates, are also driving the development of the Anxiety and Related Sleep Disorders market. As the economy continues to expand, individuals have more disposable income to spend on healthcare and are willing to invest in treatments and therapies for their mental well-being. Additionally, the government's focus on improving healthcare infrastructure and services is creating opportunities for market growth and development. Overall, the Anxiety and Related Sleep Disorders market in United Arab Emirates is experiencing significant growth due to increasing customer preferences for alternative therapies, the rising prevalence of mental health disorders, and various market trends and special circumstances. These factors, along with underlying macroeconomic factors, are contributing to the expansion and development of the market in the country.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights